Diabetes Health Enhancement Program to Improve Health of People With Diabetes

Robert Wood Johnson Foundation146 enrolled

Overview

Management of chronic diseases, such as diabetes, relies upon the health care providers and the patients self-care. Self management programs for diabetes that target self-empowerment tools have been found to be effective in some studies, but have not typically included individuals on Medicaid. Our goal for this trial was to observe if patients participating in such a program could decrease glycated hemoglobin levels, improve health status and improve self-care practices.

Design, Setting and Population: A Phase 3, one year prospective trial, randomized to intervention or control (usual care) with Medicaid or dual-Medicare beneficiaries, with diabetes, aged 40-85 years old residing in South King County, Washington. Intervention: A targeted, multi-component, self-management program incorporating a stage-of-change approach to overcome barriers and facilitate life-style behavior changes to achieve patient-driven health action plans for nutrition or exercise goals. Main Outcome Measures: Glycemic control (HbA1c), physical and mental health, self-care practices. Recruitment Status: Completed: participants are no longer being recruited; data analysis is complete.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

ECT

Masking

NONE

Enrollment

146

Conditions

Diabetes

Interventions

DHEPBEHAVIORAL

Eligibility

Sex: ALLMin age: 40 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Insured under Medicaid (SSI) or dual enrolled under Medicaid and Medicare for at least one year * Diagnosed type 1 or type 2 diabetes for at least 1 year (\>1 inpatient or \>2 outpatients visits with ICD-9 codes 250.00-250.9x, or prescriptions for insulin and/or oral hyperglycemic medications) * Aged 40-85 years * Geographically close to the Southeast Senior Center in South King County, Washington, and have a primary care provider (not HMO). Exclusion Criteria: * Serious kidney disease (serum creatinine \>2.5 or end-stage renal disease) * Other serious illness that would preclude one-year study participation (dementia, terminal illness, organ transplantation) * Pregnancy * Inability to given informed consent.

Locations (1)

Puget Sound Veterans Administration

Seattle, Washington, United States

Outcomes

Primary Outcomes

Reduction in glycated hemoglobin levels

Secondary Outcomes

Improvement in health status and diabetes self-care practices

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.